Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromised patients

Table 1 Clinical factors for cytomegalovirus gastrointestinal disease (univariate analysis)

	CMV-GID (n = 52)	Non-CMV-GID (n = 47)	P-value
Age (yr, mean ± SD)	46.8 ± 16.2	56.6 ± 17.8	0.050
Male sex	30	41	0.098
Immunodeficiency disease
HIV infection	33	12	< 0.001
Malignancy	9	10	0.617
Solid cancer	1	3
Hematological cancer	8	7
Autoimmune disease	7	11	0.200
Disorders of biochemical homeostasis	8	11	0.312
Chronic renal failure	1	2
Liver cirrhosis	0	2
Diabetes mellitus	7	7
Transplantation	1	2
Immunosuppressive therapy	25	25	0.611
Steroids	22	19
Immunosuppressants	8	4
Chemotherapy	4	4
Positive CMV antigenemia	34	3	< 0.001
Leukopenia	35	21	0.023
With gastrointestinal symptoms	34	34	0.456

HIV: Human immunodeficiency virus; CMV: Cytomegalovirus; GID: Gastrointestinal disease.